Phenotypic Profiling and Activation-Associated Expression of CD99 Ligands on Human Leukocytes

Myint Myat Thu1,2, Nuchjira Takheaw1,2, Witida Laopajon1,2

  • 1Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.

Biology
|January 10, 2026
PubMed

Insights

CD99 ligand expression varies across immune cells, with higher levels on NK cells and monocytes, especially after IL-2 activation. This suggests CD99 ligands indicate immune activation and subset-specific regulation.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • The immune system is a dynamic network of cells crucial for defense and homeostasis.
  • Immunophenotyping is vital for understanding immune response regulation.

Purpose of the Study:

  • To systematically characterize CD99 ligand expression across diverse immune cell subsets.
  • To investigate the role of CD99 ligands in immune cell activation and regulation.

Main Methods:

  • Utilized conventional and high-dimensional flow cytometry for detailed immunophenotyping.
  • Analyzed CD99 ligand expression on various immune cell populations, including NK cells, monocytes, and T lymphocytes.
  • Assessed expression changes under resting and IL-2-activated conditions.

Main Results:

  • CD99 ligands were primarily detected on NK cells and monocytes, with highest expression on non-classical monocytes and CD56 Dim NK cells.
  • IL-2 activation significantly enhanced CD99 ligand expression in these subsets.
  • T lymphocytes showed low basal CD99 ligand expression, increasing modestly upon activation, correlating with markers like CD69 and CD137.

Conclusions:

  • CD99 ligand expression is subset-specific and dynamically regulated, particularly by IL-2.
  • Elevated CD99 ligand expression, alongside activation markers, suggests a role as an indicator of immune activation.
  • These findings highlight the importance of CD99 ligands in modulating immune responses.